FDA20 closed Wednesday lower at 60.62, a decrease of -0.3861% from Tuesday's close, completing a monthly decrease of -17.0373% or -12.45. Over the past 12 months, FDA20 stock lost -43.2987%.
FDA20 is not paying dividends to its shareholders.
The stock of the company had never split.
The company's stock is traded on 13 different exchanges and in various currencies, with the primary listing on XPAR (EUR).